AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2,169 Cr | ₹-1,021 Cr | ₹223 Cr | ₹-1,164 Cr | ₹2,563 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹2,169 Cr |
| Mar2024 | ₹-1,021 Cr |
| Mar2023 | ₹223 Cr |
| Mar2022 | ₹-1,164 Cr |
| Mar2021 | ₹2,563 Cr |
How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,169 Cr | Positive | |
| Mar2024 | ₹-1,021 Cr | Negative | |
| Mar2023 | ₹223 Cr | Positive | |
| Mar2022 | ₹-1,164 Cr | Negative | |
| Mar2021 | ₹2,563 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹89,077.7 Cr | -1.1% | 11% | 35.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -1.1% |
11% |
35.6% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses